203 related articles for article (PubMed ID: 30349860)
1. Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory.
Ljubenkov PA; Staffaroni AM; Rojas JC; Allen IE; Wang P; Heuer H; Karydas A; Kornak J; Cobigo Y; Seeley WW; Grinberg LT; Spina S; Fagan AM; Jerome G; Knopman D; Boeve BF; Dickerson BC; Kramer J; Miller B; Boxer AL; Rosen HJ
Ann Clin Transl Neurol; 2018 Oct; 5(10):1250-1263. PubMed ID: 30349860
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.
Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL
Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.
Scherling CS; Hall T; Berisha F; Klepac K; Karydas A; Coppola G; Kramer JH; Rabinovici G; Ahlijanian M; Miller BL; Seeley W; Grinberg LT; Rosen H; Meredith J; Boxer AL
Ann Neurol; 2014 Jan; 75(1):116-26. PubMed ID: 24242746
[TBL] [Abstract][Full Text] [Related]
5. CSF Biomarkers of Neurodegeneration in Progressive Non-fluent Aphasia and Other Forms of Frontotemporal Dementia: Clues for Pathomechanisms?
Körtvelyessy P; Heinze HJ; Prudlo J; Bittner D
Front Neurol; 2018; 9():504. PubMed ID: 30013506
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
Skillbäck T; Farahmand BY; Rosén C; Mattsson N; Nägga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
Brain; 2015 Sep; 138(Pt 9):2716-31. PubMed ID: 26133663
[TBL] [Abstract][Full Text] [Related]
7. Beyond the temporal pole: limbic memory circuit in the semantic variant of primary progressive aphasia.
Tan RH; Wong S; Kril JJ; Piguet O; Hornberger M; Hodges JR; Halliday GM
Brain; 2014 Jul; 137(Pt 7):2065-76. PubMed ID: 24844729
[TBL] [Abstract][Full Text] [Related]
8. Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology.
Peet BT; Spina S; Mundada N; La Joie R
Neurotherapeutics; 2021 Apr; 18(2):728-752. PubMed ID: 34389969
[TBL] [Abstract][Full Text] [Related]
9. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
Rohrer JD; Woollacott IO; Dick KM; Brotherhood E; Gordon E; Fellows A; Toombs J; Druyeh R; Cardoso MJ; Ourselin S; Nicholas JM; Norgren N; Mead S; Andreasson U; Blennow K; Schott JM; Fox NC; Warren JD; Zetterberg H
Neurology; 2016 Sep; 87(13):1329-36. PubMed ID: 27581216
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia.
Landqvist Waldö M; Frizell Santillo A; Passant U; Zetterberg H; Rosengren L; Nilsson C; Englund E
BMC Neurol; 2013 May; 13():54. PubMed ID: 23718879
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia.
Giuffrè GM; Quaranta D; Costantini EM; Citro S; Martellacci N; De Ninno G; Vita MG; Guglielmi V; Rossini PM; Calabresi P; Marra C
Neurobiol Dis; 2023 Oct; 186():106267. PubMed ID: 37652185
[TBL] [Abstract][Full Text] [Related]
12. Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia.
Liu AJ; Staffaroni AM; Rojas-Martinez JC; Olney NT; Alquezar-Burillo C; Ljubenkov PA; La Joie R; Fong JC; Taylor J; Karydas A; Ramos EM; Coppola G; Boxer AL; Rabinovici GD; Miller BL; Kao AW
JAMA Neurol; 2020 Mar; 77(3):358-366. PubMed ID: 31860018
[TBL] [Abstract][Full Text] [Related]
13. [Progressive nonfluent aphasia].
Murayama S; Saito Y
Brain Nerve; 2011 Oct; 63(10):1037-46. PubMed ID: 21987561
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors.
Eratne D; Keem M; Lewis C; Kang M; Walterfang M; Farrand S; Loi S; Kelso W; Cadwallader C; Berkovic SF; Li QX; Masters CL; Collins S; Santillo A; Velakoulis D;
J Neurol Sci; 2022 Nov; 442():120439. PubMed ID: 36201960
[TBL] [Abstract][Full Text] [Related]
15. CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
Alcolea D; Vilaplana E; Suárez-Calvet M; Illán-Gala I; Blesa R; Clarimón J; Lladó A; Sánchez-Valle R; Molinuevo JL; García-Ribas G; Compta Y; Martí MJ; Piñol-Ripoll G; Amer-Ferrer G; Noguera A; García-Martín A; Fortea J; Lleó A
Neurology; 2017 Jul; 89(2):178-188. PubMed ID: 28592456
[TBL] [Abstract][Full Text] [Related]
16. Single-word comprehension deficits in the nonfluent variant of primary progressive aphasia.
Schaeverbeke J; Gabel S; Meersmans K; Bruffaerts R; Liuzzi AG; Evenepoel C; Dries E; Van Bouwel K; Sieben A; Pijnenburg Y; Peeters R; Bormans G; Van Laere K; Koole M; Dupont P; Vandenberghe R
Alzheimers Res Ther; 2018 Jul; 10(1):68. PubMed ID: 30021613
[TBL] [Abstract][Full Text] [Related]
17. The Landscape Montage Technique for diagnosing frontotemporal dementia starting as primary progressive aphasia: a case report.
Takaya M; Ishii K; Kubota I; Shirakawa O
J Med Case Rep; 2020 Jan; 14(1):5. PubMed ID: 31915061
[TBL] [Abstract][Full Text] [Related]
18. Plasma Neurofilament Light Chain in Primary Progressive Aphasia and Related Disorders: Clinical Significance and Metabolic Correlates.
Matías-Guiu JA; Gómez-Pinedo U; Forero L; Pytel V; Cano F; Moreno-Ramos T; Cabrera-Martín MN; Matías-Guiu J; González-Rosa JJ
J Alzheimers Dis; 2019; 72(3):773-782. PubMed ID: 31640103
[TBL] [Abstract][Full Text] [Related]
19. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
